Ceefourin-1, a MRP4/ABCC4 inhibitor, induces apoptosis in AML cells enhanced by histamine

Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We als...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1867; no. 4; p. 130322
Main Authors Sahores, Ana, González, Angela Rodríguez, Yaneff, Agustín, May, María, Gómez, Natalia, Monczor, Federico, Fernández, Natalia, Davio, Carlos, Shayo, Carina
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.04.2023
Subjects
Online AccessGet full text
ISSN0304-4165
1872-8006
1872-8006
DOI10.1016/j.bbagen.2023.130322

Cover

Loading…
Abstract Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice. U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice. Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage. These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine. General significance: This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies. •Ceefourin-1, a specific MRP4 inhibitor, blocks cAMP extrusion in AML cells.•Ceefourin-1 induces apoptosis in AML cells, and not differentiation.•Histamine enhances ceefourin-1 proapoptotic capacity.•Ceefourin-1 can be administered intraperitoneally to mice without apparent toxicity.
AbstractList Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice. U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice. Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage. These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine. General significance: This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies.
Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice.BACKGROUNDCeefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice.U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice.METHODSU937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice.Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage.RESULTSCeefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage.These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine.CONCLUSIONSThese results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine.This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies.GENERAL SIGNIFICANCEThis work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies.
Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice. U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice. Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage. These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine. This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies.
Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in combination with histamine, an approved antileukemic agent, to induce cell differentiation or apoptosis in human acute myeloid leukemic cells. We also examine ceefourin-1 toxicity in mice. U937, HL-60, and KG1a cells were used as models for human acute myeloid leukemia. Cyclic AMP efflux was estimated by measuring intracellular and extracellular cAMP levels. Cell differentiation was assessed by levels of CD14 and CD11b by FACS, and CD88 by western blot, and by cell morphology. Apoptosis was evaluated by cleavage of caspase-3 and PARP by western blot, and by annexin V binding assay. Subacute toxicity study of ceefourin-1 was carried out in BALB/c mice. Ceefourin-1 inhibits cAMP exclusion in AML cells and promotes intracellular signaling via CREB. Ceefourin-1 leads AML cells to apoptosis and histamine potentiates this effect, without evidence of cell differentiation. Intraperitoneal administration of ceefourin-1 shows no important alterations in mice blood parameters, hepatic, and renal functions, nor signs of histologic damage. These results show that ceefourin-1 promotes apoptosis in AML cells that is enhanced by histamine. General significance: This work indicates that ceefourin-1 represents a promising molecule that could be used alone or in combination with histamine for in vivo evaluation in acute myeloid leukemia malignancies. •Ceefourin-1, a specific MRP4 inhibitor, blocks cAMP extrusion in AML cells.•Ceefourin-1 induces apoptosis in AML cells, and not differentiation.•Histamine enhances ceefourin-1 proapoptotic capacity.•Ceefourin-1 can be administered intraperitoneally to mice without apparent toxicity.
ArticleNumber 130322
Author Yaneff, Agustín
Davio, Carlos
May, María
Shayo, Carina
Sahores, Ana
González, Angela Rodríguez
Fernández, Natalia
Monczor, Federico
Gómez, Natalia
Author_xml – sequence: 1
  givenname: Ana
  surname: Sahores
  fullname: Sahores, Ana
  organization: Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Buenos Aires, Argentina
– sequence: 2
  givenname: Angela Rodríguez
  surname: González
  fullname: González, Angela Rodríguez
  organization: Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Buenos Aires, Argentina
– sequence: 3
  givenname: Agustín
  surname: Yaneff
  fullname: Yaneff, Agustín
  organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
– sequence: 4
  givenname: María
  surname: May
  fullname: May, María
  organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
– sequence: 5
  givenname: Natalia
  surname: Gómez
  fullname: Gómez, Natalia
  organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
– sequence: 6
  givenname: Federico
  surname: Monczor
  fullname: Monczor, Federico
  organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
– sequence: 7
  givenname: Natalia
  surname: Fernández
  fullname: Fernández, Natalia
  organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
– sequence: 8
  givenname: Carlos
  surname: Davio
  fullname: Davio, Carlos
  organization: Instituto de Investigaciones Farmacológicas, ININFA - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET. Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina
– sequence: 9
  givenname: Carina
  surname: Shayo
  fullname: Shayo, Carina
  email: cshayo@dna.uba.ar
  organization: Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental - Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Buenos Aires, Argentina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36773726$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKeFN0AoSxbN1Nc_scMCaYhaQJoKhGDBynKcG8ajGXuwE6S-PYnSblhQb67l-50j65wLchZiQEJeA10Dhep6v25b-wvDmlHG18ApZ-wZWYFWrNSUVmdkRTkVpYBKnpOLnPd0OrKWL8g5r5TiilUr8rNB7OOYfCjhqrDF3bev4nrzoWlE4cPOt36I6Wq6dqPDXNhTPA0x-zy9FJu7beHwcMgFhp0NDruivS92Pg_26AO-JM97e8j46mFekh-3N9-bT-X2y8fPzWZbOs7kUDInGbCaqRq0RrTW9aJnlALwVkrGtXbU1pxpsG2nO-gZCNnTGiSAmLb8krxdfE8p_h4xD-bo8_wvGzCO2TDNBWNSVdXTqFKyglrBjL55QMf2iJ05JX-06d48JjcB7xbApZhzwt44P9jBxzAk6w8GqJlrMnuz1GTmmsxS0yQW_4gf_Z-QvV9kOOX5x2My2Xmck_cJ3WC66P9v8Bc9Bajj
CitedBy_id crossref_primary_10_3390_ijms25169082
Cites_doi 10.1016/j.semcancer.2020.02.004
10.1016/j.phrs.2016.04.002
10.18632/oncotarget.2425
10.1038/nmeth.2089
10.1002/glia.22879
10.1007/s10495-011-0624-y
10.1016/j.bbrc.2003.12.166
10.1016/j.bcp.2018.11.005
10.3324/haematol.2021.279761
10.1038/cddis.2011.124
10.1002/ijc.24207
10.1016/j.bcp.2014.05.023
10.1016/0006-2952(95)00108-C
10.1160/TH17-04-0291
10.1124/mol.62.6.1506
10.1164/ajrccm.161.supplement_1.ltta-2
10.1074/jbc.R200029200
10.2174/0929867325666171229133259
10.1016/j.bcp.2005.12.037
10.1084/jem.20021129
10.1111/cts.12366
10.1124/mol.118.115444
10.1074/jbc.M110.166868
10.1038/bcj.2016.50
10.1074/jbc.M104833200
10.1158/1078-0432.CCR-08-0442
10.1139/y89-004
10.1038/sj.leu.2403494
10.1016/0145-2126(86)90340-1
10.1089/scd.2007.0060
10.3390/medicina58060695
10.3389/fgene.2020.00480
10.1124/mol.111.071134
10.1016/j.leukres.2007.09.015
10.3390/cancers6010436
10.1038/s41408-021-00425-3
10.1586/ehm.10.30
10.1038/sj.cdd.4400686
10.1124/jpet.118.249789
10.3390/molecules26041051
10.1016/0041-008X(92)90301-8
10.1007/978-3-642-14541-4_8
10.1111/febs.15344
10.1371/journal.pone.0225702
10.1615/CritRevEukarGeneExpr.v7.i1-2.100
ContentType Journal Article
Copyright 2023 Elsevier B.V.
Copyright © 2023 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2023 Elsevier B.V.
– notice: Copyright © 2023 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.bbagen.2023.130322
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
ExternalDocumentID 36773726
10_1016_j_bbagen_2023_130322
S030441652300020X
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABWVN
ABXDB
ACDAQ
ACIUM
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AFJKZ
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AATTM
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
EFLBG
7S9
L.6
ID FETCH-LOGICAL-c325t-2c52129279188eeaacf4f200113b552388c0a93281abd8d1f2145f09151143883
IEDL.DBID .~1
ISSN 0304-4165
1872-8006
IngestDate Fri Sep 05 08:36:37 EDT 2025
Fri Sep 05 05:42:19 EDT 2025
Wed Feb 19 02:25:05 EST 2025
Tue Jul 01 00:22:17 EDT 2025
Thu Apr 24 23:03:19 EDT 2025
Sat Jan 18 16:10:40 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords AML
CD
RBP
db-cAMP
DMSO
ip
e-cAMP
H2R
Ceefourin-1
cAMP
MRP4
PDE
BSA
i-cAMP
RPMI 1640
FBS
PI
MK-571
Acute myeloid leukemia
Apoptosis
Language English
License Copyright © 2023 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c325t-2c52129279188eeaacf4f200113b552388c0a93281abd8d1f2145f09151143883
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 36773726
PQID 2775619716
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2834225766
proquest_miscellaneous_2775619716
pubmed_primary_36773726
crossref_citationtrail_10_1016_j_bbagen_2023_130322
crossref_primary_10_1016_j_bbagen_2023_130322
elsevier_sciencedirect_doi_10_1016_j_bbagen_2023_130322
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta. General subjects
PublicationTitleAlternate Biochim Biophys Acta Gen Subj
PublicationYear 2023
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Oevermann, Scheitz, Starke, Köck, Kiefer, Dölken, Niessen, Greinacher, Siegmund, Zygmunt, Kroemer, Jedlitschky, Ritter (bb0155) 2009 May 15; 124
Perez, Sklar, Chigaev, Matlawska-Wasowska (bb0170) 2021 Jan; 68
Guillemin, Raffoux, Vitoux, Kogan, Soilihi, Lallemand-Breitenbach, Zhu, Janin, Daniel, Gourmel, Degos, Dombret, Lanotte, De Thé (bb0090) 2002 Nov 18; 196
Yaneff, Sahores, Gómez, Carozzo, Shayo, Davio (bb0230) 2019; 26
Huseby, Gausdal, Keen, Kjærland, Krakstad, Myhren, Brønstad, Kunick, Schwede, Genieser, Kleppe, Døskeland (bb0100) 2011 Dec 8; 2
Schneider, Rasband, Eliceiri (bb0195) 2012 Jul; 9
Fajardo, Piazza, Tinsley (bb0070) 2014 Feb 26; 6
Becerra, Aguilera-Durán, Berumen, Romo-Mancillas, García-Alcocer (bb0005) 2021 Feb 17; 26
Vogt, Mahajan-Thakur, Wolf, Bröderdorf, Vogel, Böhm, Ritter, Gräler, Oswald, Greinacher, Kroemer, Jedlitschky, Rauch (bb0210) 2018 Jan; 118
Ramirez, Sleiman, Catchpoole, Stewart (bb0180) 2000 Jun; 7
Copsel, Bruzzone, May, Beyrath, Wargon, Cany, Russel, Shayo, Davio (bb0045) 2014 Oct 15; 5
Davio, Cricco, Bergoc, Rivera (bb0050) 1995 Jun 29; 50
Delgado, Fuentes, Fernandez-Alfonso (bb0060) 2003 Jun; 9
Zhao, Li, Du, Wu, Liu, Cui, Zhang, Gao, Keep, Xiang (bb0235) 2019 Nov 27; 14
Guo, Köck, Ritter, Chen, Grube, Jedlitschky, Illmer, Ayres, Beck, Siegmund, Ehninger, Gandhi, Kroemer, Kruh, Schaich (bb0095) 2009 Mar 1; 15
Keppler (bb0125) 2011; 201
Kobsar, Heeg, Krohne, Opitz, Walter, Böck, Gambaryan, Eigenthaler (bb0130) 2008 Feb; 17
Copsel, Garcia, Diez, Vermeulem, Baldi, Bianciotti, Russel, Shayo, Davio (bb0040) 2011 Mar 4; 286
Jördens, Keitel, Karababa, Zemtsova, Bronger, Häussinger, Görg (bb0115) 2015 Nov; 63
Jehn, Osborne (bb0105) 1997; 7
Shayo, Legnazzi, Monczor, Fernández, Riveiro, Baldi, Davio (bb0200) 2004 Feb 13; 314
Chen, Lee, Kruh (bb0025) 2001 Sep 7; 276
De Kouchkovsky, Abdul-Hay (bb0055) 2016 Jul 1; 6
Becerra, Berumen, Soto-Ontiveros, García-Alcocer (bb0010) 2022 May 24; 58
Cheung, Flemming, Watt, Masada, Yu, Huynh, Conseil, Tivnan, Polinsky, Gudkov, Munoz, Vishvanath, Cooper, Henderson, Cole, Fletcher, Haber, Norris (bb0030) 2014 Sep 1; 91
Conti, Richter, Mehats, Livera, Park, Jin (bb0035) 2003 Feb 21; 278
Green, Konig (bb0080) 2020 May 27; 11
Xie, Rich, Scheitrum, Conti, Richter (bb0225) 2011 Aug; 80
Orlando, Castillo, Medrano, Solano, Maloberti, Podesta (bb0160) 2019 Jan; 159
Wolf, Grammbauer, Palankar, Tolksdorf, Moritz, Böhm, Hasan, Hafkemeyer, Greinacher, Tzvetkov, Rauch, Jedlitschky (bb0220) 2022 Mar 17
Carozzo, Yaneff, Gómez, Di Siervi, Sahores, Diez, Attorresi, Rodríguez-González, Monczor, Fernández, Abba, Shayo, Davio (bb0020) 2019 Jul; 96
Martner, Thorén, Aurelius, Söderholm, Brune, Hellstrand (bb0140) 2010 Aug; 3
Monczor, Fernández, Riveiro, Mladovan, Baldi, Shayo, Davio (bb0145) 2006 Apr 14; 71
Fernández, Monczor, Lemos, Notcovich, Baldi, Davio, Shayo (bb0075) 2002 Dec; 62
Propper, Saunders, Salisbury, Long, O’Byrne, Braybrooke, Dowsett, Taylor, Talbot, Ganesan, Harris (bb0175) 1999 Jul; 5
Nakanishi, Takashima, Uetoko, Komori, Tamai (bb0150) 2019 Feb; 368
Wiernik, Paietta, Goloubeva, Lee, Makower, Bennett, Wade, Ghosh, Kaminer, Pizzolo, Tallman, Eastern Cooperative Oncology Group (bb0215) 2004 Oct; 18
Rodger (bb0185) 2000 Feb; 161
Rodríguez González, Sahores, Díaz-Nebreda, Yaneff, Di Siervi, Gómez, Monczor, Fernández, Davio, Shayo (bb0190) 2021 Jan; 288
Lanotte, Hermouet, Gombaud-Saintonge, Dobo (bb0135) 1986; 10
Belleville-Rolland, Sassi, Decouture, Dreano, Hulot, Gaussem, Bachelot-Loza (bb0015) 2016 May; 107
Kantarjian, Kadia, DiNardo, Daver, Borthakur, Jabbour, Garcia-Manero, Konopleva, Ravandi (bb0120) 2021 Feb 22; 11
Singh, Cadeddu, Fröbel, Wilk, Bruns, Zerbini, Prenzel, Hartwig, Brünnert, Schroeder, Lehr, Haas, Czibere (bb0205) 2011 Sep; 16
Grossman, DeLuca, Zamboni, Keenan, Patrick, Herold, van Zwieten, Zacchei (bb0085) 1992 Oct; 116
Drenberg, Hu, Li, Buelow, Orwick, Gibson, Schuetz, Sparreboom, Baker (bb0065) 2016 Feb; 9
Jones, Zamboni, Belley, Champion, Charette, Ford-Hutchinson, Frenette, Gauthier, Leger, Masson (bb0110) 1989 Jan; 67
Peng, Shi, Damaraju, Huang, Kruh, Wu, Zhou, Tiwari, Fu, Cass, Chen (bb0165) 2008 May; 32
Lanotte (10.1016/j.bbagen.2023.130322_bb0135) 1986; 10
Fajardo (10.1016/j.bbagen.2023.130322_bb0070) 2014; 6
Copsel (10.1016/j.bbagen.2023.130322_bb0045) 2014; 5
Grossman (10.1016/j.bbagen.2023.130322_bb0085) 1992; 116
Guillemin (10.1016/j.bbagen.2023.130322_bb0090) 2002; 196
Rodger (10.1016/j.bbagen.2023.130322_bb0185) 2000; 161
Copsel (10.1016/j.bbagen.2023.130322_bb0040) 2011; 286
Guo (10.1016/j.bbagen.2023.130322_bb0095) 2009; 15
Propper (10.1016/j.bbagen.2023.130322_bb0175) 1999; 5
Yaneff (10.1016/j.bbagen.2023.130322_bb0230) 2019; 26
Chen (10.1016/j.bbagen.2023.130322_bb0025) 2001; 276
Martner (10.1016/j.bbagen.2023.130322_bb0140) 2010; 3
Green (10.1016/j.bbagen.2023.130322_bb0080) 2020; 11
Wolf (10.1016/j.bbagen.2023.130322_bb0220) 2022
Shayo (10.1016/j.bbagen.2023.130322_bb0200) 2004; 314
Singh (10.1016/j.bbagen.2023.130322_bb0205) 2011; 16
Jördens (10.1016/j.bbagen.2023.130322_bb0115) 2015; 63
Orlando (10.1016/j.bbagen.2023.130322_bb0160) 2019; 159
Cheung (10.1016/j.bbagen.2023.130322_bb0030) 2014; 91
Conti (10.1016/j.bbagen.2023.130322_bb0035) 2003; 278
Ramirez (10.1016/j.bbagen.2023.130322_bb0180) 2000; 7
Wiernik (10.1016/j.bbagen.2023.130322_bb0215) 2004; 18
Jones (10.1016/j.bbagen.2023.130322_bb0110) 1989; 67
Vogt (10.1016/j.bbagen.2023.130322_bb0210) 2018; 118
Jehn (10.1016/j.bbagen.2023.130322_bb0105) 1997; 7
Becerra (10.1016/j.bbagen.2023.130322_bb0005) 2021; 26
Schneider (10.1016/j.bbagen.2023.130322_bb0195) 2012; 9
Fernández (10.1016/j.bbagen.2023.130322_bb0075) 2002; 62
Keppler (10.1016/j.bbagen.2023.130322_bb0125) 2011; 201
Nakanishi (10.1016/j.bbagen.2023.130322_bb0150) 2019; 368
Peng (10.1016/j.bbagen.2023.130322_bb0165) 2008; 32
Monczor (10.1016/j.bbagen.2023.130322_bb0145) 2006; 71
Xie (10.1016/j.bbagen.2023.130322_bb0225) 2011; 80
Becerra (10.1016/j.bbagen.2023.130322_bb0010) 2022; 58
Huseby (10.1016/j.bbagen.2023.130322_bb0100) 2011; 2
Rodríguez González (10.1016/j.bbagen.2023.130322_bb0190) 2021; 288
Perez (10.1016/j.bbagen.2023.130322_bb0170) 2021; 68
Davio (10.1016/j.bbagen.2023.130322_bb0050) 1995; 50
Zhao (10.1016/j.bbagen.2023.130322_bb0235) 2019; 14
Belleville-Rolland (10.1016/j.bbagen.2023.130322_bb0015) 2016; 107
Kantarjian (10.1016/j.bbagen.2023.130322_bb0120) 2021; 11
Carozzo (10.1016/j.bbagen.2023.130322_bb0020) 2019; 96
Delgado (10.1016/j.bbagen.2023.130322_bb0060) 2003; 9
Drenberg (10.1016/j.bbagen.2023.130322_bb0065) 2016; 9
Kobsar (10.1016/j.bbagen.2023.130322_bb0130) 2008; 17
Oevermann (10.1016/j.bbagen.2023.130322_bb0155) 2009; 124
De Kouchkovsky (10.1016/j.bbagen.2023.130322_bb0055) 2016; 6
References_xml – volume: 9
  start-page: 51
  year: 2016 Feb
  end-page: 59
  ident: bb0065
  article-title: ABCC4 is a determinant of cytarabine-induced cytotoxicity and myelosuppression
  publication-title: Clin. Transl. Sci.
– volume: 368
  start-page: 317
  year: 2019 Feb
  end-page: 325
  ident: bb0150
  article-title: Experimental evidence for Resecretion of PGE
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 18
  year: 2004 Oct
  ident: bb0215
  article-title: Phase II study of theophylline in chronic lymphocytic leukemia: a study of the eastern cooperative oncology group (E4998)
  publication-title: Leukemia.
– volume: 63
  start-page: 2092
  year: 2015 Nov
  end-page: 2105
  ident: bb0115
  article-title: Multidrug resistance-associated protein 4 expression in ammonia-treated cultured rat astrocytes and cerebral cortex of cirrhotic patients with hepatic encephalopathy
  publication-title: Glia.
– volume: 26
  start-page: 1270
  year: 2019
  end-page: 1307
  ident: bb0230
  article-title: MRP4/ABCC4 as a new therapeutic target: Meta-analysis to determine cAMP binding sites as a tool for drug design
  publication-title: Curr. Med. Chem.
– volume: 5
  start-page: 9308
  year: 2014 Oct 15
  end-page: 9321
  ident: bb0045
  article-title: Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia
  publication-title: Oncotarget.
– volume: 201
  start-page: 299
  year: 2011
  end-page: 323
  ident: bb0125
  article-title: Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy
  publication-title: Handb. Exp. Pharmacol.
– volume: 159
  start-page: 52
  year: 2019 Jan
  end-page: 63
  ident: bb0160
  article-title: Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression
  publication-title: Biochem. Pharmacol.
– volume: 26
  start-page: 1051
  year: 2021 Feb 17
  ident: bb0005
  article-title: Study of endogen substrates, drug substrates and inhibitors binding conformations on MRP4 and its variants by molecular docking and molecular dynamics
  publication-title: Molecules.
– volume: 10
  start-page: 1319
  year: 1986
  end-page: 1326
  ident: bb0135
  article-title: On growth regulation of the rat promyelocytic leukemia (BNML): growth inhibition and eradication of clonogenic cells by cholera toxin
  publication-title: Leuk. Res.
– volume: 68
  start-page: 199
  year: 2021 Jan
  end-page: 208
  ident: bb0170
  article-title: Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - a missed opportunity
  publication-title: Semin. Cancer Biol.
– volume: 62
  start-page: 1506
  year: 2002 Dec
  end-page: 1514
  ident: bb0075
  article-title: Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation
  publication-title: Mol. Pharmacol.
– volume: 67
  start-page: 17
  year: 1989 Jan
  end-page: 28
  ident: bb0110
  article-title: Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist
  publication-title: Can. J. Physiol. Pharmacol.
– volume: 6
  year: 2016 Jul 1
  ident: bb0055
  article-title: Acute myeloid leukemia: a comprehensive review and 2016 update
  publication-title: Blood Cancer J.
– volume: 9
  year: 2012 Jul
  ident: bb0195
  article-title: NIH image to ImageJ: 25 years of image analysis
  publication-title: Nat. Methods
– volume: 161
  start-page: S7
  year: 2000 Feb
  end-page: S10
  ident: bb0185
  article-title: From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist
  publication-title: Am. J. Respir. Crit. Care Med.
– volume: 3
  start-page: 381
  year: 2010 Aug
  end-page: 391
  ident: bb0140
  article-title: Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia
  publication-title: Expert. Rev. Hematol.
– volume: 5
  start-page: 1682
  year: 1999 Jul
  end-page: 1689
  ident: bb0175
  article-title: Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects
  publication-title: Clin. Cancer Res.
– volume: 286
  year: 2011 Mar 4
  ident: bb0040
  article-title: Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation
  publication-title: J. Biol. Chem.
– volume: 50
  start-page: 91
  year: 1995 Jun 29
  end-page: 96
  ident: bb0050
  article-title: H1 and H2 histamine receptors in N-nitroso-N-methylurea (NMU)-induced carcinomas with atypical coupling to signal transducers
  publication-title: Biochem. Pharmacol.
– volume: 9
  year: 2003 Jun
  ident: bb0060
  article-title: Histamine up-regulates phosphodiesterase IV activity in U-937 cells through H2 receptor stimulation and cAMP increase
  publication-title: Med. Sci. Monit.
– volume: 2
  year: 2011 Dec 8
  ident: bb0100
  article-title: Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription
  publication-title: Cell Death Dis.
– volume: 124
  start-page: 2303
  year: 2009 May 15
  end-page: 2311
  ident: bb0155
  article-title: Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs
  publication-title: Int. J. Cancer
– volume: 14
  year: 2019 Nov 27
  ident: bb0235
  article-title: Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport
  publication-title: PLoS One
– volume: 91
  start-page: 97
  year: 2014 Sep 1
  end-page: 108
  ident: bb0030
  article-title: High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)
  publication-title: Biochem. Pharmacol.
– volume: 118
  start-page: 132
  year: 2018 Jan
  end-page: 142
  ident: bb0210
  article-title: Release of platelet-derived Sphingosine-1-phosphate involves multidrug resistance protein 4 (MRP4/ABCC4) and is inhibited by statins
  publication-title: Thromb. Haemost.
– volume: 6
  year: 2014 Feb 26
  ident: bb0070
  article-title: The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment
  publication-title: Cancers (Basel)
– volume: 11
  start-page: 41
  year: 2021 Feb 22
  ident: bb0120
  article-title: Acute myeloid leukemia: current progress and future directions
  publication-title: Blood Cancer J.
– volume: 96
  start-page: 13
  year: 2019 Jul
  end-page: 25
  ident: bb0020
  article-title: Identification of MRP4/ABCC4 as a target for reducing the proliferation of pancreatic ductal adenocarcinoma cells by modulating the cAMP efflux
  publication-title: Mol. Pharmacol.
– volume: 17
  start-page: 81
  year: 2008 Feb
  end-page: 91
  ident: bb0130
  article-title: Cyclic nucleotide-regulated proliferation and differentiation vary in human hematopoietic progenitor cells derived from healthy persons, tumor patients, and chronic myelocytic leukemia patients
  publication-title: Stem Cells Dev.
– volume: 32
  start-page: 799
  year: 2008 May
  end-page: 809
  ident: bb0165
  article-title: Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine
  publication-title: Leuk. Res.
– volume: 11
  start-page: 480
  year: 2020 May 27
  ident: bb0080
  article-title: Treatment of acute myeloid leukemia in the era of genomics-achievements and persisting challenges
  publication-title: Front. Genet.
– volume: 196
  start-page: 1373
  year: 2002 Nov 18
  end-page: 1380
  ident: bb0090
  article-title: In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia
  publication-title: J. Exp. Med.
– year: 2022 Mar 17
  ident: bb0220
  article-title: Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets
  publication-title: Haematologica.
– volume: 288
  start-page: 229
  year: 2021 Jan
  end-page: 243
  ident: bb0190
  article-title: MRP4/ABCC4 expression is regulated by histamine in acute myeloid leukemia cells, determining cAMP efflux
  publication-title: FEBS J.
– volume: 314
  start-page: 798
  year: 2004 Feb 13
  end-page: 804
  ident: bb0200
  article-title: The time-course of cyclic AMP signaling is critical for leukemia U-937 cell differentiation
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 71
  start-page: 1219
  year: 2006 Apr 14
  end-page: 1228
  ident: bb0145
  article-title: Histamine H2 receptor overexpression induces U937 cell differentiation despite triggered mechanisms to attenuate cAMP signalling
  publication-title: Biochem. Pharmacol.
– volume: 276
  start-page: 33747
  year: 2001 Sep 7
  end-page: 33754
  ident: bb0025
  article-title: Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine
  publication-title: J. Biol. Chem.
– volume: 15
  start-page: 1762
  year: 2009 Mar 1
  end-page: 1769
  ident: bb0095
  article-title: Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival
  publication-title: Clin. Cancer Res.
– volume: 7
  start-page: 548
  year: 2000 Jun
  end-page: 555
  ident: bb0180
  article-title: Morphological and molecular evidence of differentiation during etoposide-induced apoptosis in human lymphoblastoid cells
  publication-title: Cell Death Differ.
– volume: 7
  start-page: 179
  year: 1997
  end-page: 193
  ident: bb0105
  article-title: Gene regulation associated with apoptosis
  publication-title: Crit. Rev. Eukaryot. Gene Expr.
– volume: 116
  start-page: 217
  year: 1992 Oct
  end-page: 224
  ident: bb0085
  article-title: Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists
  publication-title: Toxicol. Appl. Pharmacol.
– volume: 58
  start-page: 695
  year: 2022 May 24
  ident: bb0010
  article-title: Specific MRP4 inhibitor Ceefourin-1 enhances apoptosis induced by 6-Mercaptopurine in Jurkat leukemic cells, but not in Normal lymphoblast cell line CRL-1991
  publication-title: Medicina (Kaunas)
– volume: 107
  start-page: 381
  year: 2016 May
  end-page: 389
  ident: bb0015
  article-title: MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease
  publication-title: Pharmacol. Res.
– volume: 80
  year: 2011 Aug
  ident: bb0225
  article-title: Inactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMP
  publication-title: Mol. Pharmacol.
– volume: 16
  start-page: 889
  year: 2011 Sep
  end-page: 901
  ident: bb0205
  article-title: The non-steroidal anti-inflammatory drugs Sulindac sulfide and diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway
  publication-title: Apoptosis.
– volume: 278
  start-page: 5493
  year: 2003 Feb 21
  end-page: 5496
  ident: bb0035
  article-title: Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling
  publication-title: J. Biol. Chem.
– volume: 68
  start-page: 199
  year: 2021
  ident: 10.1016/j.bbagen.2023.130322_bb0170
  article-title: Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - a missed opportunity
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2020.02.004
– volume: 107
  start-page: 381
  year: 2016
  ident: 10.1016/j.bbagen.2023.130322_bb0015
  article-title: MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2016.04.002
– volume: 5
  start-page: 9308
  issue: 19
  year: 2014
  ident: 10.1016/j.bbagen.2023.130322_bb0045
  article-title: Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.2425
– volume: 9
  issue: 7
  year: 2012
  ident: 10.1016/j.bbagen.2023.130322_bb0195
  article-title: NIH image to ImageJ: 25 years of image analysis
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2089
– volume: 63
  start-page: 2092
  issue: 11
  year: 2015
  ident: 10.1016/j.bbagen.2023.130322_bb0115
  article-title: Multidrug resistance-associated protein 4 expression in ammonia-treated cultured rat astrocytes and cerebral cortex of cirrhotic patients with hepatic encephalopathy
  publication-title: Glia.
  doi: 10.1002/glia.22879
– volume: 16
  start-page: 889
  issue: 9
  year: 2011
  ident: 10.1016/j.bbagen.2023.130322_bb0205
  article-title: The non-steroidal anti-inflammatory drugs Sulindac sulfide and diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway
  publication-title: Apoptosis.
  doi: 10.1007/s10495-011-0624-y
– volume: 314
  start-page: 798
  issue: 3
  year: 2004
  ident: 10.1016/j.bbagen.2023.130322_bb0200
  article-title: The time-course of cyclic AMP signaling is critical for leukemia U-937 cell differentiation
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2003.12.166
– volume: 159
  start-page: 52
  year: 2019
  ident: 10.1016/j.bbagen.2023.130322_bb0160
  article-title: Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2018.11.005
– year: 2022
  ident: 10.1016/j.bbagen.2023.130322_bb0220
  article-title: Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets
  publication-title: Haematologica.
  doi: 10.3324/haematol.2021.279761
– volume: 2
  issue: 12
  year: 2011
  ident: 10.1016/j.bbagen.2023.130322_bb0100
  article-title: Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2011.124
– volume: 124
  start-page: 2303
  issue: 10
  year: 2009
  ident: 10.1016/j.bbagen.2023.130322_bb0155
  article-title: Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.24207
– volume: 5
  start-page: 1682
  issue: 7
  year: 1999
  ident: 10.1016/j.bbagen.2023.130322_bb0175
  article-title: Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects
  publication-title: Clin. Cancer Res.
– volume: 91
  start-page: 97
  issue: 1
  year: 2014
  ident: 10.1016/j.bbagen.2023.130322_bb0030
  article-title: High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2014.05.023
– volume: 50
  start-page: 91
  issue: 1
  year: 1995
  ident: 10.1016/j.bbagen.2023.130322_bb0050
  article-title: H1 and H2 histamine receptors in N-nitroso-N-methylurea (NMU)-induced carcinomas with atypical coupling to signal transducers
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/0006-2952(95)00108-C
– volume: 118
  start-page: 132
  issue: 1
  year: 2018
  ident: 10.1016/j.bbagen.2023.130322_bb0210
  article-title: Release of platelet-derived Sphingosine-1-phosphate involves multidrug resistance protein 4 (MRP4/ABCC4) and is inhibited by statins
  publication-title: Thromb. Haemost.
  doi: 10.1160/TH17-04-0291
– volume: 62
  start-page: 1506
  issue: 6
  year: 2002
  ident: 10.1016/j.bbagen.2023.130322_bb0075
  article-title: Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.62.6.1506
– volume: 161
  start-page: S7
  issue: 2 Pt 2
  year: 2000
  ident: 10.1016/j.bbagen.2023.130322_bb0185
  article-title: From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.161.supplement_1.ltta-2
– volume: 278
  start-page: 5493
  issue: 8
  year: 2003
  ident: 10.1016/j.bbagen.2023.130322_bb0035
  article-title: Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.R200029200
– volume: 26
  start-page: 1270
  issue: 7
  year: 2019
  ident: 10.1016/j.bbagen.2023.130322_bb0230
  article-title: MRP4/ABCC4 as a new therapeutic target: Meta-analysis to determine cAMP binding sites as a tool for drug design
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867325666171229133259
– volume: 71
  start-page: 1219
  issue: 8
  year: 2006
  ident: 10.1016/j.bbagen.2023.130322_bb0145
  article-title: Histamine H2 receptor overexpression induces U937 cell differentiation despite triggered mechanisms to attenuate cAMP signalling
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2005.12.037
– volume: 196
  start-page: 1373
  issue: 10
  year: 2002
  ident: 10.1016/j.bbagen.2023.130322_bb0090
  article-title: In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20021129
– volume: 9
  start-page: 51
  issue: 1
  year: 2016
  ident: 10.1016/j.bbagen.2023.130322_bb0065
  article-title: ABCC4 is a determinant of cytarabine-induced cytotoxicity and myelosuppression
  publication-title: Clin. Transl. Sci.
  doi: 10.1111/cts.12366
– volume: 96
  start-page: 13
  issue: 1
  year: 2019
  ident: 10.1016/j.bbagen.2023.130322_bb0020
  article-title: Identification of MRP4/ABCC4 as a target for reducing the proliferation of pancreatic ductal adenocarcinoma cells by modulating the cAMP efflux
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.118.115444
– volume: 286
  issue: 9
  year: 2011
  ident: 10.1016/j.bbagen.2023.130322_bb0040
  article-title: Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.166868
– volume: 6
  issue: 7
  year: 2016
  ident: 10.1016/j.bbagen.2023.130322_bb0055
  article-title: Acute myeloid leukemia: a comprehensive review and 2016 update
  publication-title: Blood Cancer J.
  doi: 10.1038/bcj.2016.50
– volume: 276
  start-page: 33747
  issue: 36
  year: 2001
  ident: 10.1016/j.bbagen.2023.130322_bb0025
  article-title: Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M104833200
– volume: 15
  start-page: 1762
  issue: 5
  year: 2009
  ident: 10.1016/j.bbagen.2023.130322_bb0095
  article-title: Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-0442
– volume: 67
  start-page: 17
  issue: 1
  year: 1989
  ident: 10.1016/j.bbagen.2023.130322_bb0110
  article-title: Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist
  publication-title: Can. J. Physiol. Pharmacol.
  doi: 10.1139/y89-004
– volume: 18
  issue: 10
  year: 2004
  ident: 10.1016/j.bbagen.2023.130322_bb0215
  article-title: Phase II study of theophylline in chronic lymphocytic leukemia: a study of the eastern cooperative oncology group (E4998)
  publication-title: Leukemia.
  doi: 10.1038/sj.leu.2403494
– volume: 10
  start-page: 1319
  issue: 11
  year: 1986
  ident: 10.1016/j.bbagen.2023.130322_bb0135
  article-title: On growth regulation of the rat promyelocytic leukemia (BNML): growth inhibition and eradication of clonogenic cells by cholera toxin
  publication-title: Leuk. Res.
  doi: 10.1016/0145-2126(86)90340-1
– volume: 17
  start-page: 81
  issue: 1
  year: 2008
  ident: 10.1016/j.bbagen.2023.130322_bb0130
  article-title: Cyclic nucleotide-regulated proliferation and differentiation vary in human hematopoietic progenitor cells derived from healthy persons, tumor patients, and chronic myelocytic leukemia patients
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2007.0060
– volume: 58
  start-page: 695
  issue: 6
  year: 2022
  ident: 10.1016/j.bbagen.2023.130322_bb0010
  article-title: Specific MRP4 inhibitor Ceefourin-1 enhances apoptosis induced by 6-Mercaptopurine in Jurkat leukemic cells, but not in Normal lymphoblast cell line CRL-1991
  publication-title: Medicina (Kaunas)
  doi: 10.3390/medicina58060695
– volume: 11
  start-page: 480
  year: 2020
  ident: 10.1016/j.bbagen.2023.130322_bb0080
  article-title: Treatment of acute myeloid leukemia in the era of genomics-achievements and persisting challenges
  publication-title: Front. Genet.
  doi: 10.3389/fgene.2020.00480
– volume: 80
  issue: 2
  year: 2011
  ident: 10.1016/j.bbagen.2023.130322_bb0225
  article-title: Inactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMP
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.111.071134
– volume: 32
  start-page: 799
  issue: 5
  year: 2008
  ident: 10.1016/j.bbagen.2023.130322_bb0165
  article-title: Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine
  publication-title: Leuk. Res.
  doi: 10.1016/j.leukres.2007.09.015
– volume: 6
  issue: 1
  year: 2014
  ident: 10.1016/j.bbagen.2023.130322_bb0070
  article-title: The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers6010436
– volume: 11
  start-page: 41
  issue: 2
  year: 2021
  ident: 10.1016/j.bbagen.2023.130322_bb0120
  article-title: Acute myeloid leukemia: current progress and future directions
  publication-title: Blood Cancer J.
  doi: 10.1038/s41408-021-00425-3
– volume: 3
  start-page: 381
  issue: 4
  year: 2010
  ident: 10.1016/j.bbagen.2023.130322_bb0140
  article-title: Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia
  publication-title: Expert. Rev. Hematol.
  doi: 10.1586/ehm.10.30
– volume: 7
  start-page: 548
  issue: 6
  year: 2000
  ident: 10.1016/j.bbagen.2023.130322_bb0180
  article-title: Morphological and molecular evidence of differentiation during etoposide-induced apoptosis in human lymphoblastoid cells
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4400686
– volume: 9
  issue: 6
  year: 2003
  ident: 10.1016/j.bbagen.2023.130322_bb0060
  article-title: Histamine up-regulates phosphodiesterase IV activity in U-937 cells through H2 receptor stimulation and cAMP increase
  publication-title: Med. Sci. Monit.
– volume: 368
  start-page: 317
  issue: 2
  year: 2019
  ident: 10.1016/j.bbagen.2023.130322_bb0150
  article-title: Experimental evidence for Resecretion of PGE2 across rat alveolar epithelium by OATP2A1/SLCO2A1-mediated transcellular transport
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.118.249789
– volume: 26
  start-page: 1051
  issue: 4
  year: 2021
  ident: 10.1016/j.bbagen.2023.130322_bb0005
  article-title: Study of endogen substrates, drug substrates and inhibitors binding conformations on MRP4 and its variants by molecular docking and molecular dynamics
  publication-title: Molecules.
  doi: 10.3390/molecules26041051
– volume: 116
  start-page: 217
  issue: 2
  year: 1992
  ident: 10.1016/j.bbagen.2023.130322_bb0085
  article-title: Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/0041-008X(92)90301-8
– volume: 201
  start-page: 299
  year: 2011
  ident: 10.1016/j.bbagen.2023.130322_bb0125
  article-title: Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy
  publication-title: Handb. Exp. Pharmacol.
  doi: 10.1007/978-3-642-14541-4_8
– volume: 288
  start-page: 229
  issue: 1
  year: 2021
  ident: 10.1016/j.bbagen.2023.130322_bb0190
  article-title: MRP4/ABCC4 expression is regulated by histamine in acute myeloid leukemia cells, determining cAMP efflux
  publication-title: FEBS J.
  doi: 10.1111/febs.15344
– volume: 14
  issue: 11
  year: 2019
  ident: 10.1016/j.bbagen.2023.130322_bb0235
  article-title: Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0225702
– volume: 7
  start-page: 179
  issue: 1–2
  year: 1997
  ident: 10.1016/j.bbagen.2023.130322_bb0105
  article-title: Gene regulation associated with apoptosis
  publication-title: Crit. Rev. Eukaryot. Gene Expr.
  doi: 10.1615/CritRevEukarGeneExpr.v7.i1-2.100
SSID ssj0000595
Score 2.4039998
Snippet Ceefourin-1 is a specific MRP4/ABCC4 inhibitor with potential antileukemic activity. In this study, we evaluate the ability of ceefourin-1 alone or in...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 130322
SubjectTerms Acute myeloid leukemia
Animals
Apoptosis
ATP-Binding Cassette Transporters
blood
cAMP
caspase-3
Ceefourin-1
cell differentiation
cell structures
cyclic AMP
histamine
Histamine - pharmacology
histology
Humans
intraperitoneal injection
Leukemia, Myeloid, Acute - metabolism
Mice
MRP4
Multidrug Resistance-Associated Proteins
myeloid leukemia
subacute toxicity
Western blotting
Title Ceefourin-1, a MRP4/ABCC4 inhibitor, induces apoptosis in AML cells enhanced by histamine
URI https://dx.doi.org/10.1016/j.bbagen.2023.130322
https://www.ncbi.nlm.nih.gov/pubmed/36773726
https://www.proquest.com/docview/2775619716
https://www.proquest.com/docview/2834225766
Volume 1867
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhpTSX0qbNo4-gQo9R15ZkWz5uTcP2sSG0DWxOQrIk4pB6l3hzyKW_vTOWndBDGujNlscgZvT4NJr5hpD3TpjE8zxjIckdkyIxrKyVZIWvASQlZXABHfrz43x2Kr8sssUGqcZcGAyrHNb-uKb3q_XQMhm0OVk1zeQHXuoBnEC3JoKeBWawywL58z_8vgvzAPiQxZsEyVB6TJ_rY7yshUmLLKhcYFlkwfl929N98LPfho6ekacDfqTT2MXnZMO32-RxrCh5s02eVGMBtxfkrPI-oI-9ZekhNXT-_UROph-rStKmPW8szOWrQ3h0YN2OmtVytV52TQctdDr_RtGl31HfnvcxAtTeUOQmNr8Alr4kp0efflYzNlRSYLXg2ZrxGlN0S16UqVLeG1MHGTCaKhU2AwUqVScGkJxKjXXKpQH5ywNACYBjEr6KHbLZLlu_R6iH84fMjEtL52RwyvpU2VDUFs5B0MT3iRgVqOuBZhyrXVzqMZ7sQke1a1S7jmrfJ-z2r1Wk2XhAvhhto_8aLhp2ggf-fDeaUoM9UJem9cvrTvOiADCJlFr_kFFCcjyjgcxuHAe3_RV5gTV_8lf_3bfXZAvfYmDQG7K5vrr2bwHzrO1BP6gPyKPp56-z4z_ABvvU
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYoqKKXqtAXLaVG6hFrE9tJnOMSFS2wu6pakLYny45tkarNrshy4N93Jg9QDxSJW2SPJWtmPP48mQchX5wwkedpwkKUOiZFZFheKskyXwJIivLgAjr0Z_N0cinPFsligxRDLgyGVfa2v7PprbXuR0Y9N0erqhr9wJ96ACfQrYmgZ_GMbGF1KlD2rfHp-WR-b5CTtvkK0jNcMGTQtWFe1sK5xUKoXGBnZMH5QzfUQwi0vYlOXpGXPYSk426XO2TD17vkeddU8naXbBdDD7fX5GfhfUA3e83iI2ro7Ps3ORofF4WkVX1VWTjO10fw6UDADTWr5Wq9bKoGRuh4NqXo1W-or6_aMAFqbymWJzZ_AJm-IZcnXy-KCeubKbBS8GTNeIlZujnP8lgp740pgwwYUBULmwAPlSojA2BOxcY65eKAJcwDoAlAZBJmxVuyWS9r_55QD08QmRgX587J4JT1sbIhKy08hWCI7xExMFCXfaVxbHjxWw8hZb90x3aNbNcd2_cIu1u16iptPEKfDbLR_2iMhsvgkZWHgyg1yAN5aWq_vGk0zzLAk1hV6z80SkiOzzSgedfpwd1-RZph25_0w5P39plsTy5mUz09nZ9_JC9wposT2ieb6-sb_wkg0Noe9Cr-F2pM_oU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ceefourin-1%2C+a+MRP4%2FABCC4+inhibitor%2C+induces+apoptosis+in+AML+cells+enhanced+by+histamine&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Sahores%2C+Ana&rft.au=Gonz%C3%A1lez%2C+Angela+Rodr%C3%ADguez&rft.au=Yaneff%2C+Agust%C3%ADn&rft.au=May%2C+Mar%C3%ADa&rft.date=2023-04-01&rft.issn=0304-4165&rft_id=info:doi/10.1016%2Fj.bbagen.2023.130322&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon